Luis Alvarez, MD
Nephrology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 3 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 052722 · 052793 · 552514 · 552746 · Sequoia Hospital · Washington Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Alvarez’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A69276 · Current
Licensed to practise in California · since 1999 · expires 2026-11-30 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$179,237
Medicare paid this office $179,237 for 352 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 192 | $36,262 | $116 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 20 | $27,672 | $266 |
| Short return visit (20+ min) | 162 | $27,569 | $84 |
| Home dialysis services per month (20 years or older) | 11 | $20,511 | $266 |
| Dialysis services, 1 physician visit per month (20 years or older) | 22 | $16,489 | $183 |
See all 10 services
| Return visit (30+ min) | 192 | $36,262 | $116 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 20 | $27,672 | $266 |
| Short return visit (20+ min) | 162 | $27,569 | $84 |
| Home dialysis services per month (20 years or older) | 11 | $20,511 | $266 |
| Dialysis services, 1 physician visit per month (20 years or older) | 22 | $16,489 | $183 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 12 | $15,497 | None |
| Long return visit (40+ min) | 49 | $10,540 | $160 |
| New patient visit (30+ min) | 55 | $5,319 | $97 |
| New patient visit (45+ min) | 33 | $5,062 | $153 |
| Injection of drug or substance under skin or into muscle | 12 | $1,004 | $14 |
Who their Medicare patients are
352 Original Medicare patients in 2024. Average age 78 · Under 65 5% · 85 and older 23% · Women 38% · Also on Medicaid 12% · Health risk score 2.38. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 48% · Coronary heart disease 39% · Atrial fibrillation 28% · Heart failure 24% · Cancer 22% · Depression 20% · COPD 10% · Dementia 9% · Stroke 7%.
The office billed $729,303, Medicare allowed $232,668 and paid $179,237; for 7,993 services of 23 kinds; $15,497 of it was for drugs given in the office and $163,740 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 352 | 7,993 | 78 | 2.38 | $729,303 | $179,237 |
| 2023 | 335 | 8,779 | 78 | 2.49 | $699,009 | $176,937 |
| 2022 | 317 | 3,495 | 77 | 2.59 | $590,500 | $168,399 |
| 2021 | 300 | 5,444 | 76 | 2.76 | $648,247 | $183,812 |
| 2020 | 303 | 7,184 | 76 | 3.04 | $685,650 | $164,319 |
| 2019 | 294 | 7,262 | 76 | 3.10 | $702,783 | $176,328 |
| 2018 | 307 | 6,237 | 76 | 3.23 | $690,345 | $175,047 |
| 2017 | 319 | 5,582 | 75 | 3.00 | $700,614 | $179,904 |
| 2016 | 363 | 5,064 | 75 | 2.63 | $677,815 | $179,510 |
| 2015 | 331 | 3,071 | 74 | 2.87 | $633,326 | $175,091 |
| 2014 | 314 | 3,493 | 74 | 2.84 | $626,283 | $166,892 |
| 2013 | 301 | 3,836 | 74 | 3.15 | $633,441 | $165,645 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 181 | $35,922 | $114 |
| Short return visit (20+ min) | 169 | $26,963 | $82 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $23,664 | $272 |
| Dialysis services, 1 physician visit per month (20 years or older) | 24 | $22,757 | $190 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 16 | $17,804 | None |
| Long return visit (40+ min) | 48 | $13,452 | $170 |
| New patient visit (30+ min) | 47 | $4,518 | $96 |
| New patient visit (45+ min) | 27 | $4,224 | $156 |
| Injection of drug or substance under skin or into muscle | 16 | $1,018 | $14 |
2022: 9 services
| Return visit (30+ min) | 158 | $32,515 | $116 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $28,507 | $274 |
| Short return visit (20+ min) | 161 | $27,088 | $81 |
| Dialysis services, 1 physician visit per month (20 years or older) | 29 | $26,684 | $189 |
| Long return visit (40+ min) | 38 | $9,750 | $174 |
| New patient visit (45+ min) | 33 | $4,848 | $147 |
| New patient visit (30+ min) | 36 | $3,838 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,758 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,799 | $60 |
2021: 10 services
| Return visit (30+ min) | 169 | $39,686 | $117 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 37 | $38,668 | $276 |
| Dialysis services, 1 physician visit per month (20 years or older) | 34 | $31,191 | $191 |
| Short return visit (20+ min) | 128 | $16,823 | $81 |
| Long return visit (40+ min) | 40 | $12,124 | $173 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 16 | $10,911 | None |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 16 | $7,644 | $332 |
| New patient visit (45+ min) | 30 | $4,205 | $140 |
| New patient visit (30+ min) | 36 | $3,496 | $97 |
| Injection of drug or substance under skin or into muscle | 16 | $645 | $14 |
2020: 9 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 37 | $33,909 | $222 |
| Return visit (30+ min) | 144 | $29,419 | $96 |
| Dialysis services, 1 physician visit per month (20 years or older) | 34 | $23,629 | $174 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 19 | $22,765 | $259 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 13 | $17,662 | None |
| Short return visit (20+ min) | 141 | $14,685 | $67 |
| New patient visit (30+ min) | 59 | $5,997 | $102 |
| New patient visit (45+ min) | 13 | $1,804 | $139 |
| Injection of drug or substance under skin or into muscle | 13 | $873 | $13 |
2019: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 25 | $34,410 | $259 |
| Return visit (30+ min) | 164 | $33,485 | $96 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 34 | $33,282 | $219 |
| Dialysis services, 1 physician visit per month (20 years or older) | 29 | $24,901 | $169 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 15 | $18,015 | None |
| Short return visit (20+ min) | 113 | $14,842 | $67 |
| New patient visit (30+ min) | 40 | $3,760 | $94 |
| New patient visit (45+ min) | 12 | $1,821 | $152 |
| Injection of drug or substance under skin or into muscle | 15 | $1,086 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,058 | $66 |
2018: 13 services
| Return visit (30+ min) | 195 | $36,876 | $92 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 36 | $29,934 | $215 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 20 | $28,904 | $256 |
| Dialysis services, 1 physician visit per month (20 years or older) | 30 | $21,600 | $169 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17 | $14,729 | None |
| Home dialysis services per month (20 years or older) | 13 | $13,681 | $210 |
| Short return visit (20+ min) | 96 | $11,355 | $65 |
| New patient visit (45+ min) | 21 | $3,129 | $149 |
| New patient visit (30+ min) | 24 | $2,425 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,300 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,927 | $88 |
| Hemodialysis procedure with physician evaluation | 13 | $1,743 | $62 |
| Injection of drug or substance under skin or into muscle | 17 | $966 | $21 |
2017: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 22 | $38,261 | $255 |
| Return visit (30+ min) | 183 | $35,294 | $90 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $28,088 | $214 |
| Home dialysis services per month (20 years or older) | 13 | $22,100 | $203 |
| Dialysis services, 1 physician visit per month (20 years or older) | 24 | $16,898 | $167 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 12 | $12,834 | None |
| Short return visit (20+ min) | 101 | $11,473 | $63 |
| New patient visit (45+ min) | 27 | $3,312 | $123 |
| New patient visit (30+ min) | 40 | $3,312 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $2,265 | $91 |
| Injection of drug or substance under skin or into muscle | 14 | $1,193 | $25 |
| Automated urinalysis test | 12 | $36 | $3 |
2016: 9 services
| Return visit (30+ min) | 191 | $35,092 | $91 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 23 | $29,239 | $254 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 33 | $27,698 | $213 |
| Home dialysis services per month (20 years or older) | 16 | $24,764 | $213 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $14,546 | $167 |
| Short return visit (20+ min) | 132 | $14,493 | $62 |
| New patient visit (45+ min) | 48 | $6,583 | $137 |
| New patient visit (30+ min) | 64 | $5,777 | $90 |
| Manual urinalysis test with examination using microscope, automated | 56 | $234 | $4 |
2015: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 22 | $32,451 | $266 |
| Return visit (30+ min) | 163 | $30,145 | $96 |
| Home dialysis services per month (20 years or older) | 14 | $26,441 | $224 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 29 | $25,726 | $224 |
| Dialysis services, 1 physician visit per month (20 years or older) | 27 | $19,113 | $172 |
| Short return visit (20+ min) | 129 | $16,025 | $66 |
| New patient visit (45+ min) | 37 | $5,817 | $157 |
| New patient visit (30+ min) | 48 | $4,839 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,665 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,086 | $95 |
| Manual urinalysis test with examination using microscope, automated | 38 | $160 | $4 |
2014: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 22 | $32,590 | $255 |
| Return visit (30+ min) | 163 | $29,705 | $93 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 36 | $24,091 | $215 |
| Home dialysis services per month (20 years or older) | 11 | $20,010 | $215 |
| Dialysis services, 1 physician visit per month (20 years or older) | 26 | $17,512 | $165 |
| Short return visit (20+ min) | 129 | $17,472 | $64 |
| New patient visit (30+ min) | 49 | $4,557 | $93 |
| New patient visit (45+ min) | 26 | $3,673 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,474 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,151 | $82 |
| Manual urinalysis test with examination using microscope, automated | 38 | $173 | $4 |
2013: 13 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 38 | $31,011 | $212 |
| Home dialysis services per month (20 years or older) | 13 | $25,782 | $213 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 20 | $24,008 | $250 |
| Dialysis services, 1 physician visit per month (20 years or older) | 33 | $21,081 | $163 |
| Return visit (30+ min) | 116 | $20,967 | $90 |
| Short return visit (20+ min) | 148 | $18,525 | $60 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 11 | $6,564 | None |
| New patient visit (30+ min) | 39 | $3,824 | $98 |
| New patient visit (45+ min) | 17 | $2,565 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,711 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,494 | $62 |
| Injection of drug or substance under skin or into muscle | 14 | $739 | $25 |
| Manual urinalysis test with examination using microscope, automated | 28 | $124 | $4 |
Drugs they prescribed that Part D paid
$396,235
Pharmacies billed $396,235 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (19 of 1,949) in 2024. Above the middle of the specialty; the typical nephrology clinician is at 0%.
1,658 generic and fewer than 11 brand-name prescriptions · $396,235 in drug cost · 32 antibiotic prescriptions to 21 people · 12 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Veltassa | 32 | $77,069 | $2,408 |
| Velphoro | 24 | $70,721 | $2,947 |
| Kerendia | 35 | $56,785 | $1,622 |
| Farxiga | 33 | $41,631 | $1,262 |
| Eliquis | 30 | $27,323 | $911 |
See all 47 drugs
| Veltassa | 32 | $77,069 | $2,408 |
| Velphoro | 24 | $70,721 | $2,947 |
| Kerendia | 35 | $56,785 | $1,622 |
| Farxiga | 33 | $41,631 | $1,262 |
| Eliquis | 30 | $27,323 | $911 |
| Jardiance | 12 | $21,045 | $1,754 |
| Sevelamer Carbonate | 47 | $19,366 | $412 |
| Cinacalcet | 12 | $17,207 | $1,434 |
| Prosol | 71 | $7,770 | $109 |
| Tacrolimus | 13 | $4,426 | $340 |
| Clinolipid | 13 | $2,762 | $212 |
| Midodrine | 22 | $2,542 | $116 |
| Eplerenone | 14 | $1,710 | $122 |
| Clonidine | 13 | $1,570 | $121 |
| Losartan | 139 | $1,495 | $11 |
| Olmesartan Medoxomil | 26 | $1,133 | $44 |
| Amlodipine Besylate | 146 | $971 | $7 |
| Gabapentin | 46 | $889 | $19 |
| Clonidine | 48 | $847 | $18 |
| Valsartan | 15 | $745 | $50 |
| Allopurinol | 58 | $720 | $12 |
| Carvedilol | 48 | $687 | $14 |
| Calcium Acetate | 16 | $651 | $41 |
| Lisinopril | 96 | $643 | $7 |
| Prednisone | 55 | $624 | $11 |
| Calcitriol | 59 | $617 | $10 |
| Omega-3 Acid Ethyl Esters | 13 | $602 | $46 |
| Hydrochlorothiazide | 86 | $586 | $7 |
| Furosemide | 73 | $518 | $7 |
| Pantoprazole | 21 | $511 | $24 |
| Nifedipine Er | 18 | $461 | $26 |
| Atorvastatin | 67 | $429 | $6 |
| Quetiapine | 12 | $393 | $33 |
| Tamsulosin | 14 | $372 | $27 |
| Minoxidil | 12 | $344 | $29 |
| Zolpidem | 22 | $340 | $15 |
| Mirtazapine | 17 | $327 | $19 |
| Metoprolol | 25 | $316 | $13 |
| Spironolactone | 25 | $311 | $12 |
| Omeprazole | 14 | $293 | $21 |
| Chlorthalidone | 31 | $216 | $7 |
| Lorazepam | 30 | $196 | $7 |
| Metoprolol | 16 | $144 | $9 |
| Hydralazine | 20 | $132 | $7 |
| Benazepril | 11 | $76 | $7 |
| Losartan-Hydrochlorothiazide | 16 | $71 | $4 |
| Simvastatin | 26 | $42 | $2 |
Year by year
| 2024 | 1,949 | 241 | 1% (19) | None | $396,235 |
| 2023 | 1,888 | 232 | 1% (23) | None | $473,926 |
| 2022 | 1,796 | 223 | 2% (33) | None | $475,908 |
| 2021 | 1,861 | 214 | 2% (37) | 11% | $361,389 |
| 2020 | 1,856 | 208 | 4% (74) | None | $377,382 |
| 2019 | 1,781 | 195 | 4% (70) | None | $272,753 |
| 2018 | 1,942 | 208 | 3% (55) | None | $330,935 |
| 2017 | 2,052 | 219 | 3% (56) | None | $476,699 |
| 2016 | 2,134 | 224 | 2% (42) | None | $436,639 |
| 2015 | 2,024 | 198 | 3% (53) | None | $369,572 |
| 2014 | 1,931 | 190 | 4% (72) | None | $319,905 |
| 2013 | 2,090 | 193 | 4% (74) | None | $301,515 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 41 drugs
| Velphoro | 21 | $98,062 | $4,670 |
| Veltassa | 31 | $78,350 | $2,527 |
| Sevelamer Carbonate | 48 | $36,613 | $763 |
| Kerendia | 17 | $31,103 | $1,830 |
| Eliquis | 31 | $31,064 | $1,002 |
| Farxiga | 13 | $21,310 | $1,639 |
| Prosol | 54 | $6,918 | $128 |
| Tacrolimus | 18 | $4,747 | $264 |
| Losartan | 141 | $2,526 | $18 |
| Amlodipine Besylate | 140 | $1,543 | $11 |
| Lisinopril | 100 | $1,451 | $15 |
| Clonidine | 17 | $1,417 | $83 |
| Omega-3 Acid Ethyl Esters | 16 | $1,403 | $88 |
| Furosemide | 97 | $1,240 | $13 |
| Midodrine | 15 | $1,133 | $76 |
| Allopurinol | 50 | $1,078 | $22 |
| Atorvastatin | 82 | $999 | $12 |
| Calcitriol | 59 | $976 | $17 |
| Carvedilol | 55 | $772 | $14 |
| Valsartan | 17 | $682 | $40 |
| Clonidine | 32 | $674 | $21 |
| Gabapentin | 36 | $654 | $18 |
| Prednisone | 74 | $622 | $8 |
| Chlorthalidone | 21 | $614 | $29 |
| Minoxidil | 17 | $599 | $35 |
| Metoprolol | 30 | $505 | $17 |
| Hydrochlorothiazide | 71 | $502 | $7 |
| Losartan-Hydrochlorothiazide | 20 | $375 | $19 |
| Metoprolol | 22 | $354 | $16 |
| Mirtazapine | 11 | $346 | $31 |
| Tamsulosin | 15 | $335 | $22 |
| Pantoprazole | 14 | $310 | $22 |
| Benazepril | 18 | $308 | $17 |
| Zolpidem | 21 | $302 | $14 |
| Levothyroxine | 11 | $263 | $24 |
| Lorazepam | 17 | $251 | $15 |
| Omeprazole | 16 | $220 | $14 |
| Spironolactone | 13 | $146 | $11 |
| Cephalexin | 13 | $131 | $10 |
| Acetaminophen-Codeine | 11 | $131 | $12 |
| Simvastatin | 32 | $85 | $3 |
2022: 43 drugs
| Velphoro | 16 | $72,265 | $4,517 |
| Veltassa | 20 | $36,794 | $1,840 |
| Sevelamer Carbonate | 48 | $33,307 | $694 |
| Eliquis | 20 | $21,658 | $1,083 |
| Kerendia | 16 | $14,525 | $908 |
| Jardiance | 11 | $11,603 | $1,055 |
| Tacrolimus | 28 | $6,797 | $243 |
| Prosol | 44 | $5,299 | $120 |
| Losartan | 127 | $1,815 | $14 |
| Olmesartan Medoxomil | 12 | $1,802 | $150 |
| Lisinopril | 101 | $1,590 | $16 |
| Clonidine | 16 | $1,589 | $99 |
| Mycophenolate Mofetil | 26 | $1,513 | $58 |
| Amlodipine Besylate | 135 | $1,479 | $11 |
| Furosemide | 99 | $1,435 | $14 |
| Omega-3 Acid Ethyl Esters | 14 | $1,196 | $85 |
| Atorvastatin | 69 | $1,085 | $16 |
| Calcitriol | 56 | $943 | $17 |
| Prednisone | 63 | $942 | $15 |
| Allopurinol | 51 | $922 | $18 |
| Mirtazapine | 18 | $779 | $43 |
| Carvedilol | 42 | $760 | $18 |
| Methenamine Hippurate | 11 | $723 | $66 |
| Clonidine | 56 | $650 | $12 |
| Tamsulosin | 20 | $601 | $30 |
| Gabapentin | 30 | $473 | $16 |
| Metoprolol | 30 | $447 | $15 |
| Escitalopram | 15 | $430 | $29 |
| Metoprolol | 19 | $349 | $18 |
| Hydrochlorothiazide | 76 | $339 | $4 |
| Omeprazole | 19 | $314 | $17 |
| Chlorthalidone | 17 | $288 | $17 |
| Levothyroxine | 13 | $284 | $22 |
| Losartan-Hydrochlorothiazide | 17 | $219 | $13 |
| Simvastatin | 29 | $216 | $7 |
| Zolpidem | 15 | $197 | $13 |
| Hydralazine | 19 | $187 | $10 |
| Lorazepam | 17 | $165 | $10 |
| Pantoprazole | 11 | $146 | $13 |
| Benazepril | 12 | $94 | $8 |
| Sertraline | 13 | $73 | $6 |
| Spironolactone | 11 | $42 | $4 |
| Sulfamethoxazole-Trimethoprim | 12 | $13 | $1 |
2021: 42 drugs
| Veltassa | 32 | $57,394 | $1,794 |
| Sevelamer Carbonate | 44 | $41,509 | $943 |
| Renvela | 14 | $38,164 | $2,726 |
| Eliquis | 27 | $22,461 | $832 |
| Jardiance | 11 | $10,949 | $995 |
| Tacrolimus | 27 | $7,031 | $260 |
| Cinacalcet | 11 | $5,111 | $465 |
| Retacrit | 17 | $5,040 | $296 |
| Calcitriol | 85 | $2,731 | $32 |
| Losartan | 115 | $2,076 | $18 |
| Furosemide | 108 | $1,708 | $16 |
| Atorvastatin | 67 | $1,221 | $18 |
| Amlodipine Besylate | 145 | $1,186 | $8 |
| Mycophenolate Mofetil | 16 | $1,107 | $69 |
| Lisinopril | 77 | $1,038 | $13 |
| Clonidine | 69 | $966 | $14 |
| Prednisone | 46 | $692 | $15 |
| Gabapentin | 47 | $681 | $14 |
| Carvedilol | 46 | $668 | $15 |
| Chlorthalidone | 27 | $641 | $24 |
| Metoprolol | 27 | $627 | $23 |
| Allopurinol | 54 | $621 | $12 |
| Hydrochlorothiazide | 110 | $610 | $6 |
| Mirtazapine | 27 | $587 | $22 |
| Minoxidil | 11 | $581 | $53 |
| Nifedipine Er | 12 | $559 | $47 |
| Fentanyl | 11 | $552 | $50 |
| Methenamine Hippurate | 12 | $535 | $45 |
| Metoprolol | 29 | $508 | $18 |
| Omeprazole | 30 | $484 | $16 |
| Losartan-Hydrochlorothiazide | 20 | $476 | $24 |
| Lorazepam | 26 | $460 | $18 |
| Tamsulosin | 26 | $450 | $17 |
| Levothyroxine | 19 | $431 | $23 |
| Fludrocortisone Acetate | 14 | $431 | $31 |
| Pantoprazole | 14 | $377 | $27 |
| Oxycodone | 16 | $324 | $20 |
| Escitalopram | 19 | $257 | $14 |
| Simvastatin | 30 | $213 | $7 |
| Sertraline | 17 | $113 | $7 |
| Metronidazole | 11 | $110 | $10 |
| Spironolactone | 13 | $52 | $4 |
2020: 43 drugs
| Veltassa | 37 | $49,820 | $1,346 |
| Renvela | 14 | $44,753 | $3,197 |
| Sevelamer Carbonate | 57 | $33,496 | $588 |
| Procrit | 13 | $27,442 | $2,111 |
| Velphoro | 11 | $13,610 | $1,237 |
| Cinacalcet | 19 | $12,400 | $653 |
| Tacrolimus | 28 | $5,863 | $209 |
| Calcitriol | 96 | $4,003 | $42 |
| Eliquis | 15 | $3,970 | $265 |
| Chlorthalidone | 24 | $1,614 | $67 |
| Furosemide | 95 | $1,611 | $17 |
| Proair Hfa | 22 | $1,469 | $67 |
| Losartan | 101 | $1,374 | $14 |
| Calcium Acetate | 12 | $1,320 | $110 |
| Midodrine | 11 | $1,182 | $107 |
| Amlodipine Besylate | 138 | $1,119 | $8 |
| Nifedipine Er | 20 | $1,071 | $54 |
| Mycophenolate Mofetil | 18 | $1,003 | $56 |
| Atorvastatin | 51 | $991 | $19 |
| Methenamine Hippurate | 13 | $959 | $74 |
| Lisinopril | 67 | $888 | $13 |
| Clonidine | 58 | $847 | $15 |
| Allopurinol | 55 | $835 | $15 |
| Carvedilol | 58 | $738 | $13 |
| Oxycodone | 21 | $725 | $35 |
| Fentanyl | 12 | $640 | $53 |
| Hydrochlorothiazide | 102 | $634 | $6 |
| Tamsulosin | 32 | $588 | $18 |
| Minoxidil | 11 | $451 | $41 |
| Mirtazapine | 16 | $445 | $28 |
| Omeprazole | 21 | $428 | $20 |
| Prednisone | 32 | $395 | $12 |
| Levothyroxine | 15 | $366 | $24 |
| Gabapentin | 26 | $348 | $13 |
| Hydrocodone-Acetaminophen | 20 | $346 | $17 |
| Metoprolol | 19 | $267 | $14 |
| Acetaminophen-Codeine | 19 | $257 | $14 |
| Lorazepam | 23 | $251 | $11 |
| Simvastatin | 32 | $248 | $8 |
| Zolpidem | 11 | $188 | $17 |
| Sertraline | 17 | $136 | $8 |
| Spironolactone | 11 | $60 | $5 |
| Cephalexin | 12 | $57 | $5 |
2019: 37 drugs
| Veltassa | 45 | $57,695 | $1,282 |
| Velphoro | 12 | $36,545 | $3,045 |
| Sevelamer Carbonate | 58 | $34,505 | $595 |
| Renvela | 15 | $28,323 | $1,888 |
| Procrit | 12 | $25,332 | $2,111 |
| Tacrolimus | 17 | $5,184 | $305 |
| Calcitriol | 95 | $3,710 | $39 |
| Omega-3 Acid Ethyl Esters | 15 | $1,994 | $133 |
| Olmesartan Medoxomil | 11 | $1,929 | $175 |
| Mycophenolate Mofetil | 21 | $1,861 | $89 |
| Furosemide | 93 | $1,753 | $19 |
| Chlorthalidone | 20 | $1,708 | $85 |
| Amlodipine Besylate | 126 | $1,275 | $10 |
| Losartan | 94 | $1,121 | $12 |
| Allopurinol | 47 | $1,092 | $23 |
| Atorvastatin | 45 | $1,004 | $22 |
| Methenamine Hippurate | 12 | $858 | $72 |
| Carvedilol | 54 | $799 | $15 |
| Clonidine | 54 | $754 | $14 |
| Lisinopril | 77 | $735 | $10 |
| Gabapentin | 35 | $595 | $17 |
| Hydrochlorothiazide | 80 | $594 | $7 |
| Prednisone | 56 | $527 | $9 |
| Oxycodone | 18 | $488 | $27 |
| Metoprolol | 12 | $430 | $36 |
| Hydrocodone-Acetaminophen | 19 | $418 | $22 |
| Levothyroxine | 19 | $403 | $21 |
| Simvastatin | 41 | $392 | $10 |
| Tamsulosin | 13 | $371 | $29 |
| Pantoprazole | 12 | $309 | $26 |
| Omeprazole | 26 | $293 | $11 |
| Metoprolol | 45 | $273 | $6 |
| Acetaminophen-Codeine | 15 | $267 | $18 |
| Zolpidem | 19 | $260 | $14 |
| Lorazepam | 29 | $174 | $6 |
| Lovastatin | 11 | $125 | $11 |
| Cephalexin | 12 | $87 | $7 |
2018: 40 drugs
| Renvela | 48 | $102,708 | $2,140 |
| Veltassa | 63 | $75,494 | $1,198 |
| Sevelamer Carbonate | 61 | $55,968 | $918 |
| Xarelto | 13 | $5,849 | $450 |
| Tacrolimus | 23 | $5,182 | $225 |
| Calcitriol | 113 | $4,782 | $42 |
| Omega-3 Acid Ethyl Esters | 16 | $2,379 | $149 |
| Mycophenolate Mofetil | 22 | $2,321 | $106 |
| Amlodipine Besylate | 146 | $1,760 | $12 |
| Losartan | 120 | $1,316 | $11 |
| Allopurinol | 36 | $1,140 | $32 |
| Furosemide | 100 | $941 | $9 |
| Nifedipine Er | 13 | $847 | $65 |
| Lisinopril | 85 | $780 | $9 |
| Clonidine | 53 | $750 | $14 |
| Carvedilol | 82 | $737 | $9 |
| Atorvastatin | 33 | $655 | $20 |
| Gabapentin | 31 | $589 | $19 |
| Hydrochlorothiazide | 87 | $563 | $6 |
| Metoprolol | 15 | $546 | $36 |
| Omeprazole | 35 | $532 | $15 |
| Levothyroxine | 18 | $493 | $27 |
| Fentanyl | 12 | $488 | $41 |
| Tamsulosin | 24 | $471 | $20 |
| Prednisone | 41 | $433 | $11 |
| Oxycodone | 11 | $377 | $34 |
| Hydralazine | 14 | $361 | $26 |
| Simvastatin | 51 | $317 | $6 |
| Acetaminophen-Codeine | 13 | $259 | $20 |
| Metoprolol | 48 | $229 | $5 |
| Amiloride | 11 | $214 | $19 |
| Irbesartan | 12 | $214 | $18 |
| Lovastatin | 11 | $205 | $19 |
| Lisinopril-Hydrochlorothiazide | 11 | $199 | $18 |
| Benazepril | 15 | $178 | $12 |
| Sertraline | 13 | $161 | $12 |
| Lorazepam | 26 | $159 | $6 |
| Triamcinolone Acetonide | 11 | $65 | $6 |
| Diazepam | 15 | $60 | $4 |
| Famotidine | 15 | $51 | $3 |
2017: 46 drugs
| Renvela | 94 | $202,578 | $2,155 |
| Sensipar | 46 | $87,479 | $1,902 |
| Veltassa | 50 | $58,157 | $1,163 |
| Sevelamer Carbonate | 11 | $15,866 | $1,442 |
| Hectorol | 13 | $4,741 | $365 |
| Xarelto | 11 | $4,241 | $386 |
| Calcitriol | 103 | $3,317 | $32 |
| Tacrolimus | 21 | $2,569 | $122 |
| Omega-3 Acid Ethyl Esters | 12 | $1,987 | $166 |
| Chlorthalidone | 25 | $1,728 | $69 |
| Amlodipine Besylate | 151 | $1,431 | $9 |
| Midodrine | 14 | $1,139 | $81 |
| Losartan | 104 | $1,112 | $11 |
| Allopurinol | 42 | $1,105 | $26 |
| Lisinopril | 94 | $1,013 | $11 |
| Nifedipine Er | 16 | $906 | $57 |
| Carvedilol | 76 | $722 | $10 |
| Furosemide | 100 | $699 | $7 |
| Tamsulosin | 21 | $683 | $33 |
| Potassium Chloride | 19 | $679 | $36 |
| Atorvastatin | 29 | $621 | $21 |
| Levothyroxine | 23 | $613 | $27 |
| Hydrochlorothiazide | 92 | $598 | $7 |
| Clonidine | 52 | $533 | $10 |
| Valsartan | 11 | $518 | $47 |
| Prednisone | 34 | $447 | $13 |
| Minoxidil | 11 | $388 | $35 |
| Labetalol | 12 | $379 | $32 |
| Oxycodone | 11 | $373 | $34 |
| Omeprazole | 32 | $346 | $11 |
| Hydrocodone-Acetaminophen | 21 | $323 | $15 |
| Simvastatin | 49 | $321 | $7 |
| Gabapentin | 21 | $303 | $14 |
| Metoprolol | 56 | $294 | $5 |
| Benazepril | 12 | $275 | $23 |
| Lorazepam | 43 | $261 | $6 |
| Sertraline | 19 | $257 | $14 |
| Zolpidem | 15 | $207 | $14 |
| Torsemide | 12 | $158 | $13 |
| Acetaminophen-Codeine | 11 | $142 | $13 |
| Irbesartan | 12 | $121 | $10 |
| Cephalexin | 15 | $77 | $5 |
| Diazepam | 18 | $75 | $4 |
| Famotidine | 16 | $69 | $4 |
| Atenolol | 13 | $61 | $5 |
| Alendronate | 11 | $39 | $4 |
2016: 46 drugs
| Renvela | 130 | $236,106 | $1,816 |
| Sensipar | 46 | $59,833 | $1,301 |
| Doxercalciferol | 19 | $24,646 | $1,297 |
| Veltassa | 28 | $19,826 | $708 |
| Hectorol | 11 | $4,011 | $365 |
| Tacrolimus | 26 | $2,751 | $106 |
| Calcitriol | 71 | $2,292 | $32 |
| Prosol | 13 | $1,907 | $147 |
| Amlodipine Besylate | 170 | $1,475 | $9 |
| Valsartan | 26 | $1,365 | $52 |
| Chlorthalidone | 11 | $1,214 | $110 |
| Clonidine | 13 | $1,184 | $91 |
| Nifedipine Er | 16 | $1,162 | $73 |
| Lisinopril | 128 | $999 | $8 |
| Losartan | 81 | $983 | $12 |
| Furosemide | 142 | $931 | $7 |
| Allopurinol | 49 | $923 | $19 |
| Hydrochlorothiazide | 118 | $815 | $7 |
| Levothyroxine | 27 | $701 | $26 |
| Clonidine | 67 | $678 | $10 |
| Mycophenolate Mofetil | 15 | $677 | $45 |
| Carvedilol | 77 | $672 | $9 |
| Midodrine | 13 | $672 | $52 |
| Hydrocodone-Acetaminophen | 21 | $668 | $32 |
| Atorvastatin | 32 | $584 | $18 |
| Tamsulosin | 22 | $571 | $26 |
| Gabapentin | 27 | $546 | $20 |
| Minoxidil | 16 | $486 | $30 |
| Terazosin | 12 | $427 | $36 |
| Simvastatin | 47 | $416 | $9 |
| Metoprolol | 67 | $402 | $6 |
| Labetalol | 11 | $398 | $36 |
| Temazepam | 15 | $374 | $25 |
| Zolpidem | 12 | $369 | $31 |
| Warfarin | 15 | $305 | $20 |
| Prednisone | 23 | $295 | $13 |
| Famotidine | 20 | $292 | $15 |
| Omeprazole | 24 | $242 | $10 |
| Lorazepam | 42 | $220 | $5 |
| Metoclopramide | 12 | $201 | $17 |
| Ramipril | 11 | $186 | $17 |
| Benazepril | 14 | $158 | $11 |
| Sertraline | 15 | $112 | $7 |
| Alendronate | 16 | $106 | $7 |
| Diazepam | 21 | $93 | $4 |
| Cephalexin | 12 | $66 | $6 |
2015: 40 drugs
| Renvela | 125 | $170,821 | $1,367 |
| Sensipar | 50 | $60,975 | $1,219 |
| Doxercalciferol | 24 | $40,755 | $1,698 |
| Velphoro | 16 | $21,626 | $1,352 |
| Hectorol | 14 | $5,342 | $382 |
| Clinisol | 24 | $2,941 | $123 |
| Calcitriol | 64 | $2,343 | $37 |
| Clonidine | 12 | $2,031 | $169 |
| Tacrolimus | 16 | $1,977 | $124 |
| Valsartan | 14 | $1,644 | $117 |
| Allopurinol | 59 | $1,076 | $18 |
| Nifedipine Er | 15 | $1,037 | $69 |
| Furosemide | 148 | $998 | $7 |
| Carvedilol | 95 | $968 | $10 |
| Amlodipine Besylate | 136 | $898 | $7 |
| Midodrine | 12 | $853 | $71 |
| Levothyroxine | 22 | $732 | $33 |
| Hydrocodone-Acetaminophen | 26 | $728 | $28 |
| Kionex | 18 | $725 | $40 |
| Lisinopril | 90 | $700 | $8 |
| Minoxidil | 24 | $581 | $24 |
| Hydrochlorothiazide | 89 | $549 | $6 |
| Losartan | 44 | $544 | $12 |
| Zolpidem | 20 | $531 | $27 |
| Atorvastatin | 27 | $525 | $19 |
| Clonidine | 73 | $515 | $7 |
| Gabapentin | 30 | $393 | $13 |
| Tamsulosin | 19 | $387 | $20 |
| Simvastatin | 58 | $348 | $6 |
| Terazosin | 12 | $334 | $28 |
| Metoprolol | 61 | $306 | $5 |
| Omeprazole | 40 | $298 | $7 |
| Temazepam | 12 | $297 | $25 |
| Prednisone | 20 | $223 | $11 |
| Clopidogrel | 16 | $218 | $14 |
| Famotidine | 27 | $217 | $8 |
| Lorazepam | 33 | $125 | $4 |
| Metoclopramide | 11 | $120 | $11 |
| Diazepam | 26 | $114 | $4 |
| Alendronate | 17 | $107 | $6 |
2014: 46 drugs
| Renvela | 96 | $122,016 | $1,271 |
| Sensipar | 68 | $63,783 | $938 |
| Sevelamer Carbonate | 37 | $28,464 | $769 |
| Hectorol | 22 | $26,117 | $1,187 |
| Diovan | 13 | $5,452 | $419 |
| Calcitriol | 94 | $3,619 | $39 |
| Coreg Cr | 11 | $1,817 | $165 |
| Carvedilol | 102 | $1,520 | $15 |
| Atorvastatin | 32 | $1,197 | $37 |
| Nifedipine Er | 12 | $1,156 | $96 |
| Amlodipine Besylate | 135 | $1,155 | $9 |
| Furosemide | 170 | $1,086 | $6 |
| Gabapentin | 36 | $1,015 | $28 |
| Kionex | 21 | $985 | $47 |
| Zolpidem Tartrate Er | 12 | $895 | $75 |
| Oxycodone | 18 | $819 | $46 |
| Potassium Chloride | 14 | $754 | $54 |
| Lisinopril | 76 | $669 | $9 |
| Hydrochlorothiazide | 82 | $657 | $8 |
| Hydralazine | 13 | $649 | $50 |
| Minoxidil | 27 | $613 | $23 |
| Clonidine | 47 | $531 | $11 |
| Hydrocodone-Acetaminophen | 25 | $518 | $21 |
| Losartan | 25 | $510 | $20 |
| Levothyroxine | 21 | $499 | $24 |
| Allopurinol | 52 | $483 | $9 |
| Omeprazole | 33 | $351 | $11 |
| Simvastatin | 45 | $341 | $8 |
| Metoprolol | 43 | $309 | $7 |
| Terazosin | 15 | $292 | $19 |
| Labetalol | 12 | $269 | $22 |
| Prednisone | 20 | $266 | $13 |
| Tamsulosin | 12 | $228 | $19 |
| Clopidogrel | 15 | $202 | $13 |
| Mirtazapine | 11 | $184 | $17 |
| Benazepril | 13 | $174 | $13 |
| Metoclopramide | 16 | $148 | $9 |
| Zolpidem | 12 | $130 | $11 |
| Alendronate | 17 | $112 | $7 |
| Famotidine | 12 | $101 | $8 |
| Donepezil | 13 | $99 | $8 |
| Acetaminophen-Codeine | 12 | $76 | $6 |
| Cephalexin | 13 | $75 | $6 |
| Tramadol | 12 | $67 | $6 |
| Levofloxacin | 11 | $66 | $6 |
| Diazepam | 19 | $61 | $3 |
2013: 41 drugs
| Renvela | 130 | $143,813 | $1,106 |
| Sensipar | 74 | $52,201 | $705 |
| Hectorol | 35 | $27,923 | $798 |
| Diovan | 20 | $6,395 | $320 |
| Calcium Acetate | 17 | $3,405 | $200 |
| Calcitriol | 75 | $2,866 | $38 |
| Effient | 12 | $2,624 | $219 |
| Carvedilol | 117 | $2,132 | $18 |
| Amlodipine Besylate | 140 | $1,791 | $13 |
| Coreg Cr | 12 | $1,781 | $148 |
| Atorvastatin | 48 | $1,671 | $35 |
| Lantus | 11 | $1,624 | $148 |
| Nifedipine Er | 15 | $1,592 | $106 |
| Gabapentin | 67 | $1,372 | $20 |
| Clopidogrel | 23 | $1,322 | $57 |
| Hydralazine | 29 | $1,318 | $45 |
| Zolpidem Tartrate Er | 12 | $1,250 | $104 |
| Furosemide | 156 | $1,138 | $7 |
| Lisinopril | 106 | $1,008 | $10 |
| Potassium Chloride | 23 | $991 | $43 |
| Minoxidil | 39 | $897 | $23 |
| Omeprazole | 32 | $832 | $26 |
| Losartan | 30 | $810 | $27 |
| Hydrochlorothiazide | 81 | $764 | $9 |
| Metoprolol | 19 | $752 | $40 |
| Clonidine | 48 | $613 | $13 |
| Ventolin Hfa | 12 | $511 | $43 |
| Simvastatin | 32 | $429 | $13 |
| Diltiazem 24hr Er | 13 | $414 | $32 |
| Allopurinol | 50 | $381 | $8 |
| Hydrocodone-Acetaminophen | 47 | $376 | $8 |
| Tamsulosin | 17 | $368 | $22 |
| Metoprolol | 38 | $338 | $9 |
| Zolpidem | 31 | $318 | $10 |
| Fluoxetine | 14 | $272 | $19 |
| Benazepril | 18 | $213 | $12 |
| Levothyroxine | 12 | $173 | $14 |
| Prednisone | 21 | $134 | $6 |
| Alendronate | 11 | $101 | $9 |
| Diazepam | 24 | $69 | $3 |
| Tramadol | 12 | $67 | $6 |
Money from drug and device companies
$370,261 in 2025
| 2025 | 17 | 477 | $303,287 | $370,261 |
| 2024 | 16 | 382 | $226,816 | $274,215 |
| 2023 | 14 | 229 | $179,079 | $209,993 |
| 2022 | 10 | 199 | $222,477 | $240,358 |
| 2021 | 9 | 116 | $90,613 | $101,291 |
| 2020 | 10 | 64 | $459,997 | $461,913 |
| 2019 | 9 | 183 | $145,415 | $156,923 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Tavneos | $138,948 | 120 payments
|
| Calliditas Therapeutics US | Tarpeyo | $88,239 | 94 payments
|
| Akebia Therapeutics | Vafseo | $56,677 | 95 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $24,466 | 36 payments
|
| Novartis Pharmaceuticals | Fabhalta | $18,396 | 29 payments
|
| Travere Therapeutics | Filspari | $17,395 | 36 payments
|
See all 477 published payments
| Novartis Pharmaceuticals | Meals · 2025-12-24 | Vanrafia | $35 |
| Novartis Pharmaceuticals | Consulting · 2025-12-23 | Fabhalta | $875 |
| Calliditas Therapeutics US | Honoraria · 2025-12-18 | Tarpeyo | $2,000 |
| Akebia Therapeutics | Paid to speak or teach · 2025-12-18 | Vafseo | $1,144 |
| Akebia Therapeutics | Paid to speak or teach · 2025-12-18 | Vafseo | $1,430 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-12-17 | Kerendia | $318 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-12-17 | Kerendia | $223 |
| Travere Therapeutics | Travel · 2025-12-17 | Filspari | $84 |
| Amgen | Travel · 2025-12-16 | Tavneos | $103 |
| Amgen | Paid to speak or teach · 2025-12-16 | Tavneos | $3,360 |
| Amgen | Meals · 2025-12-16 | Tavneos | $48 |
| Akebia Therapeutics | Meals · 2025-12-16 | Vafseo | $145 |
| Akebia Therapeutics | Travel · 2025-12-16 | Vafseo | $255 |
| Akebia Therapeutics | Travel · 2025-12-16 | Vafseo | $88 |
| Amgen | Travel · 2025-12-15 | None | $139 |
| Amgen | Paid to speak or teach · 2025-12-15 | Tavneos | $3,360 |
| Amgen | Paid to speak or teach · 2025-12-15 | Tavneos | $1,120 |
| Amgen | Travel · 2025-12-15 | None | $87 |
| Amgen | Paid to speak or teach · 2025-12-15 | Tavneos | $2,800 |
| Amgen | Meals · 2025-12-15 | Tavneos | $122 |
| Amgen | Travel · 2025-12-11 | Tavneos | $466 |
| Amgen | Meals · 2025-12-11 | Tavneos | $125 |
| Calliditas Therapeutics US | Honoraria · 2025-12-11 | Tarpeyo | $3,000 |
| Novartis Pharmaceuticals | Meals · 2025-12-10 | Fabhalta | $18 |
| Otsuka Pharmaceutical Development & Commercialization | Consulting · 2025-12-10 | None | $3,930 |
| Otsuka Pharmaceutical Development & Commercialization | Consulting · 2025-12-10 | None | $1,179 |
| Otsuka Pharmaceutical Development & Commercialization | Consulting · 2025-12-10 | None | $2,358 |
| Amgen | Travel · 2025-12-10 | None | $412 |
| Travere Therapeutics | Paid to speak or teach · 2025-12-10 | Filspari | $2,100 |
| Otsuka Pharmaceutical Development & Commercialization | Travel · 2025-12-08 | None | $95 |
| Otsuka Pharmaceutical Development & Commercialization | Travel · 2025-12-08 | None | $39 |
| Otsuka Pharmaceutical Development & Commercialization | Travel · 2025-12-08 | None | $62 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-12-08 | None | $33 |
| Calliditas Therapeutics US | Travel · 2025-12-07 | Tarpeyo | $143 |
| Calliditas Therapeutics US | Travel · 2025-12-07 | Tarpeyo | $641 |
| Travere Therapeutics | Meals · 2025-12-05 | Filspari | $32 |
| Travere Therapeutics | Meals · 2025-12-05 | Filspari | $32 |
| Travere Therapeutics | Meals · 2025-12-05 | Filspari | $62 |
| Travere Therapeutics | Meals · 2025-12-05 | Filspari | $71 |
| Travere Therapeutics | Travel · 2025-12-05 | Filspari | $315 |
| Travere Therapeutics | Travel · 2025-12-05 | Filspari | $559 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-12-03 | Kerendia | $2,625 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-11-28 | Kerendia | $241 |
| Novartis Pharmaceuticals | Paid to speak or teach · 2025-11-26 | None | $1,500 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-11-26 | Kerendia | $3,413 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-11-26 | Kerendia | $2,888 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-11-26 | Kerendia | $2,888 |
| Amgen | Travel · 2025-11-26 | Tavneos | $16 |
| Amgen | Paid to speak or teach · 2025-11-26 | Tavneos | $3,360 |
| Amgen | Travel · 2025-11-26 | Tavneos | $454 |
| Amgen | Travel · 2025-11-26 | Tavneos | $110 |
| Amgen | Paid to speak or teach · 2025-11-26 | Tavneos | $560 |
| Amgen | Meals · 2025-11-26 | Tavneos | $23 |
| Calliditas Therapeutics US | Honoraria · 2025-11-25 | Tarpeyo | $3,000 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-11-21 | Kerendia | $145 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-11-21 | Kerendia | $8 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-21 | Kerendia | $17 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-11-21 | Kerendia | $8 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-11-21 | Kerendia | $118 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-11-20 | Kerendia | $262 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-18 | Kerendia | $86 |
| Travere Therapeutics | Meals · 2025-11-18 | None | $28 |
| Travere Therapeutics | Travel · 2025-11-18 | None | $134 |
| Travere Therapeutics | Consulting · 2025-11-18 | None | $6,000 |
| Akebia Therapeutics | Paid to speak or teach · 2025-11-17 | Vafseo | $1,144 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-11-15 | None | $50 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-11-15 | None | $25 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-11-15 | None | $50 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-11-15 | None | $35 |
| Otsuka Pharmaceutical Development & Commercialization | Travel · 2025-11-14 | None | $431 |
| Otsuka Pharmaceutical Development & Commercialization | Travel · 2025-11-14 | None | $219 |
| Novartis Pharmaceuticals | Meals · 2025-11-12 | Fabhalta | $12 |
| Calliditas Therapeutics US | Travel · 2025-11-12 | Tarpeyo | $29 |
| Otsuka America Pharmaceutical | Meals · 2025-11-06 | None | $147 |
| Calliditas Therapeutics US | Honoraria · 2025-11-06 | Tarpeyo | $3,000 |
| Amgen | Meals · 2025-11-05 | Tavneos | $57 |
| Akebia Therapeutics | Meals · 2025-11-05 | Auryxia | $123 |
| Amgen | Consulting · 2025-11-04 | Tavneos | $9,160 |
| Amgen | Travel · 2025-11-04 | Tavneos | $268 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-10-31 | Kerendia | $3,413 |
| Calliditas Therapeutics US | Travel · 2025-10-30 | Tarpeyo | $1,265 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-29 | Kerendia | $24 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-10-29 | Kerendia | $185 |
| Amgen | Travel · 2025-10-29 | None | $369 |
| Amgen | Meals · 2025-10-29 | Tavneos | $125 |
| Calliditas Therapeutics US | Meals · 2025-10-29 | Tarpeyo | $14 |
| Calliditas Therapeutics US | Travel · 2025-10-29 | Tarpeyo | $149 |
| Calliditas Therapeutics US | Travel · 2025-10-29 | Tarpeyo | $659 |
| Fresenius USA Marketing | Travel · 2025-10-27 | Velphoro | $500 |
| Fresenius USA Marketing | Consulting · 2025-10-27 | Velphoro | $2,000 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-10-25 | Kerendia | $147 |
| Travere Therapeutics | Meals · 2025-10-25 | Filspari | $39 |
| Travere Therapeutics | Meals · 2025-10-25 | Filspari | $40 |
| Travere Therapeutics | Meals · 2025-10-25 | Filspari | $69 |
| Travere Therapeutics | Meals · 2025-10-25 | Filspari | $85 |
| Amgen | Consulting · 2025-10-24 | Tavneos | $528 |
| Travere Therapeutics | Travel · 2025-10-24 | Filspari | $287 |
| Travere Therapeutics | Travel · 2025-10-24 | Filspari | $428 |
| Kyowa Kirin | Meals · 2025-10-22 | Crysvita | $24 |
| Calliditas Therapeutics US | Meals · 2025-10-22 | Tarpeyo | $142 |
| Calliditas Therapeutics US | Travel · 2025-10-22 | Tarpeyo | $150 |
| Calliditas Therapeutics US | Travel · 2025-10-22 | Tarpeyo | $463 |
| Fresenius USA Marketing | Travel · 2025-10-22 | Velphoro | $10 |
| Fresenius USA Marketing | Travel · 2025-10-22 | Velphoro | $244 |
| Fresenius USA Marketing | Travel · 2025-10-22 | Velphoro | $244 |
| Fresenius USA Marketing | Meals · 2025-10-22 | Velphoro | $127 |
| Novartis Pharmaceuticals | Meals · 2025-10-21 | Fabhalta | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-17 | Kerendia | $102 |
| Lilly USA | Meals · 2025-10-16 | Jardiance | $34 |
| Calliditas Therapeutics US | Honoraria · 2025-10-16 | Tarpeyo | $2,000 |
| Calliditas Therapeutics US | Honoraria · 2025-10-16 | Tarpeyo | $3,000 |
| Akebia Therapeutics | Paid to speak or teach · 2025-10-10 | Vafseo | $1,144 |
| Akebia Therapeutics | Paid to speak or teach · 2025-10-10 | Vafseo | $1,430 |
| Akebia Therapeutics | Meals · 2025-10-10 | Vafseo | $24 |
| Calliditas Therapeutics US | Meals · 2025-10-09 | Tarpeyo | $132 |
| Akebia Therapeutics | Paid to speak or teach · 2025-10-08 | Vafseo | $1,144 |
| Akebia Therapeutics | Meals · 2025-10-08 | Vafseo | $111 |
| Akebia Therapeutics | Travel · 2025-10-08 | Vafseo | $26 |
| Akebia Therapeutics | Travel · 2025-10-08 | Vafseo | $38 |
| Akebia Therapeutics | Travel · 2025-10-08 | Vafseo | $377 |
| Travere Therapeutics | Paid to speak or teach · 2025-10-08 | Filspari | $600 |
| Fresenius USA Marketing | Travel · 2025-10-07 | Velphoro | $1,000 |
| Fresenius USA Marketing | Consulting · 2025-10-07 | Velphoro | $2,000 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-10-04 | Kerendia | $94 |
| Amgen | Meals · 2025-10-04 | Tavneos | $50 |
| Fresenius USA Marketing | Meals · 2025-10-04 | Velphoro | $8 |
| Fresenius USA Marketing | Travel · 2025-10-04 | Velphoro | $8 |
| Fresenius USA Marketing | Travel · 2025-10-04 | Velphoro | $164 |
| Fresenius USA Marketing | Travel · 2025-10-04 | Velphoro | $83 |
| Fresenius USA Marketing | Meals · 2025-10-04 | Velphoro | $13 |
| Fresenius USA Marketing | Travel · 2025-10-04 | Velphoro | $389 |
| Fresenius USA Marketing | Travel · 2025-10-04 | Velphoro | $107 |
| Fresenius USA Marketing | Travel · 2025-10-03 | Velphoro | $90 |
| Fresenius USA Marketing | Meals · 2025-10-03 | Velphoro | $42 |
| Amgen | Meals · 2025-09-26 | Tavneos | $150 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-25 | Lokelma | $26 |
| Calliditas Therapeutics US | Honoraria · 2025-09-25 | Tarpeyo | $1,500 |
| Calliditas Therapeutics US | Honoraria · 2025-09-25 | Tarpeyo | $3,000 |
| Amgen | Paid to speak or teach · 2025-09-24 | None | $3,360 |
| Calliditas Therapeutics US | Travel · 2025-09-24 | Tarpeyo | $140 |
| Calliditas Therapeutics US | Meals · 2025-09-17 | Tarpeyo | $76 |
| Calliditas Therapeutics US | Travel · 2025-09-17 | Tarpeyo | $1,876 |
| Calliditas Therapeutics US | Travel · 2025-09-17 | Tarpeyo | $367 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-16 | Lokelma | $29 |
| Calliditas Therapeutics US | Honoraria · 2025-09-11 | Tarpeyo | $4,000 |
| Novartis Pharmaceuticals | Meals · 2025-09-10 | Fabhalta | $24 |
| Novartis Pharmaceuticals | Meals · 2025-09-10 | Fabhalta | $24 |
| Akebia Therapeutics | Paid to speak or teach · 2025-09-08 | Vafseo | $1,144 |
| Akebia Therapeutics | Paid to speak or teach · 2025-09-08 | Vafseo | $1,430 |
| Calliditas Therapeutics US | Travel · 2025-09-06 | Tarpeyo | $465 |
| Calliditas Therapeutics US | Travel · 2025-09-06 | Tarpeyo | $407 |
| Akebia Therapeutics | Meals · 2025-09-04 | Vafseo | $118 |
| Akebia Therapeutics | Travel · 2025-09-04 | Vafseo | $302 |
| Akebia Therapeutics | Paid to speak or teach · 2025-09-04 | Vafseo | $1,144 |
| Calliditas Therapeutics US | Honoraria · 2025-08-28 | Tarpeyo | $2,000 |
| Amgen | Paid to speak or teach · 2025-08-26 | Tavneos | $2,800 |
| Mallinckrodt Hospital Products | Meals · 2025-08-23 | Acthar | $20 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-21 | Kerendia | $32 |
| Calliditas Therapeutics US | Honoraria · 2025-08-21 | Tarpeyo | $3,000 |
| Lilly USA | Meals · 2025-08-20 | Jardiance | $21 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-17 | Kerendia | $66 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-08-17 | Kerendia | $275 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-17 | Kerendia | $115 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-16 | Farxiga | $24 |
| Calliditas Therapeutics US | Meals · 2025-08-16 | Tarpeyo | $22 |
| Calliditas Therapeutics US | Meals · 2025-08-15 | Tarpeyo | $3 |
| Calliditas Therapeutics US | Honoraria · 2025-08-14 | Tarpeyo | $2,000 |
| Calliditas Therapeutics US | Travel · 2025-08-13 | Tarpeyo | $246 |
| Calliditas Therapeutics US | Travel · 2025-08-13 | Tarpeyo | $403 |
| Calliditas Therapeutics US | Travel · 2025-08-13 | Tarpeyo | $745 |
| Apellis Pharmaceuticals | Meals · 2025-08-13 | None | $145 |
| Novartis Pharmaceuticals | Meals · 2025-08-11 | Fabhalta | $15 |
| Novartis Pharmaceuticals | Meals · 2025-08-11 | Fabhalta | $15 |
| Novartis Pharmaceuticals | Meals · 2025-08-08 | Fabhalta | $49 |
| Novartis Pharmaceuticals | Meals · 2025-08-08 | Fabhalta | $133 |
| Novartis Pharmaceuticals | Consulting · 2025-08-08 | Fabhalta | $7,500 |
| Novartis Pharmaceuticals | Travel · 2025-08-08 | Fabhalta | $272 |
| Novartis Pharmaceuticals | Travel · 2025-08-08 | Fabhalta | $538 |
| Novartis Pharmaceuticals | Travel · 2025-08-07 | Fabhalta | $387 |
| Akebia Therapeutics | Paid to speak or teach · 2025-08-07 | Vafseo | $4,576 |
| Akebia Therapeutics | Paid to speak or teach · 2025-08-07 | Vafseo | $1,716 |
| Akebia Therapeutics | Paid to speak or teach · 2025-08-07 | Vafseo | $172 |
| Akebia Therapeutics | Paid to speak or teach · 2025-08-01 | Vafseo | $1,430 |
| Akebia Therapeutics | Paid to speak or teach · 2025-08-01 | Vafseo | $572 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-30 | Farxiga | $24 |
| Calliditas Therapeutics US | Honoraria · 2025-07-30 | Tarpeyo | $1,000 |
| Akebia Therapeutics | Meals · 2025-07-30 | Vafseo | $125 |
| Akebia Therapeutics | Travel · 2025-07-30 | Vafseo | $30 |
| Akebia Therapeutics | Paid to speak or teach · 2025-07-25 | Vafseo | $572 |
| Akebia Therapeutics | Meals · 2025-07-18 | Vafseo | $114 |
| Akebia Therapeutics | Meals · 2025-07-18 | Vafseo | $120 |
| Akebia Therapeutics | Travel · 2025-07-18 | Vafseo | $20 |
| Novartis Pharmaceuticals | Meals · 2025-07-17 | Fabhalta | $22 |
| Novartis Pharmaceuticals | Meals · 2025-07-17 | Fabhalta | $22 |
| Calliditas Therapeutics US | Honoraria · 2025-07-17 | Tarpeyo | $2,000 |
| Akebia Therapeutics | Meals · 2025-07-17 | Vafseo | $148 |
| Akebia Therapeutics | Travel · 2025-07-17 | Vafseo | $20 |
| Akebia Therapeutics | Travel · 2025-07-17 | Vafseo | $234 |
| Akebia Therapeutics | Travel · 2025-07-17 | Vafseo | $807 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-07-14 | Jardiance | $29 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-07-09 | Kerendia | $22 |
| Ardelyx | Meals · 2025-07-09 | Ibsrela | $18 |
| Alexion Pharmaceuticals | Meals · 2025-07-08 | Ultomiris | $22 |
| Kyowa Kirin | Meals · 2025-07-03 | None | $34 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-07-03 | Kerendia | $218 |
| Calliditas Therapeutics US | Travel · 2025-07-02 | Tarpeyo | $72 |
| Calliditas Therapeutics US | Travel · 2025-07-02 | Tarpeyo | $103 |
| Calliditas Therapeutics US | Meals · 2025-07-02 | Tarpeyo | $47 |
| Amgen | Paid to speak or teach · 2025-06-30 | Tavneos | $2,800 |
| Mallinckrodt Hospital Products | Meals · 2025-06-27 | Acthar | $20 |
| Novartis Pharmaceuticals | Consulting · 2025-06-26 | Fabhalta | $3,000 |
| Novartis Pharmaceuticals | Meals · 2025-06-25 | Fabhalta | $10 |
| Novartis Pharmaceuticals | Meals · 2025-06-25 | Fabhalta | $10 |
| Akebia Therapeutics | Paid to speak or teach · 2025-06-25 | Vafseo | $1,716 |
| Akebia Therapeutics | Paid to speak or teach · 2025-06-25 | Vafseo | $1,430 |
| Travere Therapeutics | Meals · 2025-06-24 | None | $122 |
| Akebia Therapeutics | Paid to speak or teach · 2025-06-23 | Vafseo | $1,430 |
| Akebia Therapeutics | Paid to speak or teach · 2025-06-23 | Vafseo | $572 |
| Amgen | Meals · 2025-06-20 | Tavneos | $30 |
| Akebia Therapeutics | Meals · 2025-06-19 | Vafseo | $29 |
| Akebia Therapeutics | Travel · 2025-06-19 | Vafseo | $258 |
| Akebia Therapeutics | Travel · 2025-06-19 | Vafseo | $339 |
| Akebia Therapeutics | Travel · 2025-06-19 | Vafseo | $708 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-18 | Jardiance | $31 |
| Akebia Therapeutics | Travel · 2025-06-18 | Vafseo | $23 |
| Akebia Therapeutics | Meals · 2025-06-18 | Vafseo | $125 |
| Kyowa Kirin | Consulting · 2025-06-16 | Crysvita | $8,330 |
| Kyowa Kirin | Meals · 2025-06-16 | Crysvita | $11 |
| Kyowa Kirin | Meals · 2025-06-16 | Crysvita | $17 |
| Kyowa Kirin | Travel · 2025-06-16 | Crysvita | $90 |
| Kyowa Kirin | Travel · 2025-06-16 | Crysvita | $69 |
| Travere Therapeutics | Travel · 2025-06-10 | Filspari | $16 |
| Travere Therapeutics | Travel · 2025-06-10 | Filspari | $215 |
| Calliditas Therapeutics US | Honoraria · 2025-06-05 | Tarpeyo | $3,000 |
| Calliditas Therapeutics US | Honoraria · 2025-06-05 | Tarpeyo | $2,000 |
| Amgen | Meals · 2025-06-04 | Tavneos | $28 |
| Travere Therapeutics | Travel · 2025-06-04 | Filspari | $1 |
| Travere Therapeutics | Travel · 2025-06-04 | Filspari | $7 |
| Travere Therapeutics | Travel · 2025-06-04 | Filspari | $80 |
| Travere Therapeutics | Paid to speak or teach · 2025-06-04 | Filspari | $2,500 |
| Akebia Therapeutics | Paid to speak or teach · 2025-06-03 | Vafseo | $572 |
| Akebia Therapeutics | Paid to speak or teach · 2025-06-03 | Vafseo | $1,430 |
| Travere Therapeutics | Paid to speak or teach · 2025-05-30 | Filspari | $2,500 |
| Calliditas Therapeutics US | Honoraria · 2025-05-28 | Tarpeyo | $3,000 |
| Calliditas Therapeutics US | Travel · 2025-05-28 | Tarpeyo | $459 |
| Calliditas Therapeutics US | Travel · 2025-05-28 | Tarpeyo | $487 |
| Calliditas Therapeutics US | Travel · 2025-05-28 | Tarpeyo | $364 |
| Akebia Therapeutics | Paid to speak or teach · 2025-05-28 | Vafseo | $1,430 |
| Akebia Therapeutics | Paid to speak or teach · 2025-05-28 | Vafseo | $1,144 |
| Calliditas Therapeutics US | Travel · 2025-05-27 | Tarpeyo | $106 |
| Calliditas Therapeutics US | Meals · 2025-05-27 | Tarpeyo | $25 |
| Calliditas Therapeutics US | Travel · 2025-05-22 | Tarpeyo | $338 |
| Calliditas Therapeutics US | Travel · 2025-05-22 | Tarpeyo | $231 |
| Calliditas Therapeutics US | Travel · 2025-05-22 | Tarpeyo | $862 |
| Calliditas Therapeutics US | Meals · 2025-05-22 | Tarpeyo | $119 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-05-21 | Kerendia | $92 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-05-21 | Kerendia | $7 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-05-21 | Kerendia | $2,888 |
| Akebia Therapeutics | Travel · 2025-05-21 | Vafseo | $34 |
| Akebia Therapeutics | Travel · 2025-05-21 | Vafseo | $38 |
| Akebia Therapeutics | Meals · 2025-05-21 | Vafseo | $123 |
| Akebia Therapeutics | Travel · 2025-05-21 | Vafseo | $206 |
| Akebia Therapeutics | Travel · 2025-05-21 | Vafseo | $203 |
| Akebia Therapeutics | Travel · 2025-05-21 | Vafseo | $203 |
| Akebia Therapeutics | Meals · 2025-05-20 | Vafseo | $19 |
| Akebia Therapeutics | Travel · 2025-05-20 | Vafseo | $174 |
| Akebia Therapeutics | Travel · 2025-05-20 | Vafseo | $16 |
| Akebia Therapeutics | Meals · 2025-05-20 | Vafseo | $100 |
| Amgen | Travel · 2025-05-19 | Tavneos | $170 |
| Amgen | Meals · 2025-05-19 | Tavneos | $57 |
| Amgen | Paid to speak or teach · 2025-05-15 | None | $3,360 |
| Amgen | Paid to speak or teach · 2025-05-15 | None | $2,240 |
| Amgen | Paid to speak or teach · 2025-05-15 | None | $3,360 |
| Amgen | Paid to speak or teach · 2025-05-15 | Tavneos | $3,360 |
| Amgen | Paid to speak or teach · 2025-05-15 | None | $2,240 |
| Travere Therapeutics | Meals · 2025-05-15 | Filspari | $87 |
| Travere Therapeutics | Travel · 2025-05-15 | Filspari | $187 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-14 | Kerendia | $125 |
| Travere Therapeutics | Meals · 2025-05-14 | Filspari | $125 |
| Amgen | Travel · 2025-05-13 | None | $166 |
| Amgen | Travel · 2025-05-13 | None | $166 |
| Amgen | Meals · 2025-05-13 | None | $35 |
| Amgen | Meals · 2025-05-13 | None | $35 |
| Kyowa Kirin | Meals · 2025-05-10 | Crysvita | $25 |
| Kyowa Kirin | Meals · 2025-05-10 | Crysvita | $50 |
| Kyowa Kirin | Meals · 2025-05-10 | Crysvita | $25 |
| Kyowa Kirin | Travel · 2025-05-10 | Crysvita | $596 |
| Kyowa Kirin | Travel · 2025-05-10 | Crysvita | $233 |
| Kyowa Kirin | Meals · 2025-05-10 | Crysvita | $49 |
| Kyowa Kirin | Meals · 2025-05-09 | Crysvita | $123 |
| Amgen | Travel · 2025-05-08 | None | $729 |
| Amgen | Paid to speak or teach · 2025-05-08 | Tavneos | $2,800 |
| Amgen | Travel · 2025-05-08 | None | $729 |
| Amgen | Meals · 2025-05-07 | Tavneos | $146 |
| Calliditas Therapeutics US | Travel · 2025-05-07 | Tarpeyo | $314 |
| Calliditas Therapeutics US | Meals · 2025-05-07 | Tarpeyo | $25 |
| Lilly USA | Meals · 2025-05-01 | Omvoh | $125 |
| Amgen | Paid to speak or teach · 2025-05-01 | Tavneos | $3,360 |
| Amgen | Travel · 2025-05-01 | Tavneos | $78 |
| Amgen | Paid to speak or teach · 2025-05-01 | Tavneos | $3,360 |
| Amgen | Travel · 2025-05-01 | Tavneos | $166 |
| Amgen | Paid to speak or teach · 2025-05-01 | Tavneos | $2,240 |
| Amgen | Meals · 2025-05-01 | Tavneos | $88 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-30 | Jardiance | $32 |
| Amgen | Travel · 2025-04-29 | Tavneos | $1,309 |
| Travere Therapeutics | Meals · 2025-04-29 | None | $24 |
| Calliditas Therapeutics US | Travel · 2025-04-28 | Tarpeyo | $349 |
| Amgen | Travel · 2025-04-26 | Tavneos | $718 |
| Amgen | Paid to speak or teach · 2025-04-24 | Tavneos | $3,360 |
| Amgen | Paid to speak or teach · 2025-04-24 | Tavneos | $3,360 |
| Amgen | Paid to speak or teach · 2025-04-24 | Tavneos | $3,360 |
| Amgen | Paid to speak or teach · 2025-04-24 | Tavneos | $2,240 |
| Calliditas Therapeutics US | Honoraria · 2025-04-24 | Tarpeyo | $3,000 |
| Bayer Healthcare Pharmaceuticals | Paid to speak or teach · 2025-04-18 | Kerendia | $2,888 |
| Bayer Healthcare Pharmaceuticals | Travel · 2025-04-18 | Kerendia | $164 |
| Amgen | Travel · 2025-04-18 | Tavneos | $221 |
| Amgen | Paid to speak or teach · 2025-04-18 | Tavneos | $560 |
| Amgen | Paid to speak or teach · 2025-04-18 | Tavneos | $3,360 |
| Calliditas Therapeutics US | Meals · 2025-04-17 | Tarpeyo | $125 |
| Calliditas Therapeutics US | Travel · 2025-04-17 | Tarpeyo | $1,405 |
| Calliditas Therapeutics US | Travel · 2025-04-17 | Tarpeyo | $473 |
| Calliditas Therapeutics US | Travel · 2025-04-17 | Tarpeyo | $141 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-16 | Farxiga | $22 |
| Calliditas Therapeutics US | Honoraria · 2025-04-16 | Tarpeyo | $4,250 |
| Amgen | Travel · 2025-04-15 | None | $360 |
| Amgen | Travel · 2025-04-15 | None | $360 |
| Novartis Pharmaceuticals | Meals · 2025-04-14 | Fabhalta | $43 |
| Novartis Pharmaceuticals | Consulting · 2025-04-14 | Fabhalta | $2,150 |
| Novartis Pharmaceuticals | Travel · 2025-04-14 | Fabhalta | $17 |
| Amgen | Travel · 2025-04-14 | Tavneos | $1,576 |
| Novartis Pharmaceuticals | Consulting · 2025-04-11 | Fabhalta | $1,500 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-11 | Kerendia | $112 |
| Amgen | Meals · 2025-04-10 | Tavneos | $126 |
| Amgen | Meals · 2025-04-10 | Tavneos | $31 |
| Calliditas Therapeutics US | Honoraria · 2025-04-10 | Tarpeyo | $3,000 |
| Calliditas Therapeutics US | Honoraria · 2025-04-10 | Tarpeyo | $3,000 |
| Amgen | Travel · 2025-04-09 | Tavneos | $699 |
| Amgen | Meals · 2025-04-09 | Tavneos | $150 |
| Calliditas Therapeutics US | Meals · 2025-04-09 | Tarpeyo | $70 |
| Calliditas Therapeutics US | Travel · 2025-04-09 | Tarpeyo | $160 |
| Calliditas Therapeutics US | Travel · 2025-04-03 | Tarpeyo | $715 |
| Calliditas Therapeutics US | Travel · 2025-04-03 | Tarpeyo | $557 |
| Calliditas Therapeutics US | Travel · 2025-04-03 | Tarpeyo | $248 |
| Calliditas Therapeutics US | Meals · 2025-04-03 | Tarpeyo | $19 |
| Calliditas Therapeutics US | Meals · 2025-04-03 | Tarpeyo | $125 |
| Calliditas Therapeutics US | Travel · 2025-03-29 | Tarpeyo | $738 |
| Calliditas Therapeutics US | Travel · 2025-03-29 | Tarpeyo | $628 |
| Calliditas Therapeutics US | Meals · 2025-03-29 | Tarpeyo | $68 |
| Calliditas Therapeutics US | Meals · 2025-03-29 | Tarpeyo | $45 |
| Calliditas Therapeutics US | Meals · 2025-03-29 | Tarpeyo | $63 |
| Calliditas Therapeutics US | Meals · 2025-03-29 | Tarpeyo | $45 |
| Amgen | Travel · 2025-03-28 | Tavneos | $185 |
| Amgen | Meals · 2025-03-28 | Tavneos | $40 |
| Calliditas Therapeutics US | Meals · 2025-03-28 | Tarpeyo | $150 |
| Amgen | Paid to speak or teach · 2025-03-27 | Tavneos | $3,360 |
| Amgen | Paid to speak or teach · 2025-03-27 | Tavneos | $1,120 |
| Amgen | Meals · 2025-03-27 | Tavneos | $93 |
| Novartis Pharmaceuticals | Meals · 2025-03-26 | Fabhalta | $28 |
| Travere Therapeutics | Paid to speak or teach · 2025-03-26 | Filspari | $500 |
| Akebia Therapeutics | Paid to speak or teach · 2025-03-24 | Vafseo | $286 |
| Amgen | Travel · 2025-03-23 | Tavneos | $370 |
| Amgen | Travel · 2025-03-22 | Tavneos | $234 |
| Amgen | Paid to speak or teach · 2025-03-20 | None | $2,800 |
| Travere Therapeutics | Meals · 2025-03-20 | None | $9 |
| Ardelyx | Meals · 2025-03-19 | Ibsrela | $27 |
| Travere Therapeutics | Meals · 2025-03-18 | None | $5 |
| Travere Therapeutics | Meals · 2025-03-18 | None | $12 |
| Calliditas Therapeutics US | Meals · 2025-03-15 | Tarpeyo | $23 |
| Novartis Pharmaceuticals | Meals · 2025-03-13 | None | $126 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-12 | Farxiga | $23 |
| Amgen | Travel · 2025-03-12 | Tavneos | $819 |
| Calliditas Therapeutics US | Travel · 2025-03-12 | Tarpeyo | $150 |
| Calliditas Therapeutics US | Meals · 2025-03-12 | Tarpeyo | $45 |
| Akebia Therapeutics | Travel · 2025-03-12 | Vafseo | $62 |
| Akebia Therapeutics | Meals · 2025-03-11 | Vafseo | $18 |
| Akebia Therapeutics | Travel · 2025-03-11 | Vafseo | $429 |
| Akebia Therapeutics | Travel · 2025-03-11 | Vafseo | $403 |
| Akebia Therapeutics | Travel · 2025-03-11 | Vafseo | $403 |
| Akebia Therapeutics | Travel · 2025-03-11 | Vafseo | $325 |
| Akebia Therapeutics | Travel · 2025-03-11 | Vafseo | $326 |
| Akebia Therapeutics | Meals · 2025-03-11 | Vafseo | $179 |
| Akebia Therapeutics | Travel · 2025-03-11 | Vafseo | $112 |
| Akebia Therapeutics | Travel · 2025-03-11 | Vafseo | $161 |
| Akebia Therapeutics | Travel · 2025-03-11 | Vafseo | $105 |
| Akebia Therapeutics | Meals · 2025-03-10 | Vafseo | $55 |
| Akebia Therapeutics | Paid to speak or teach · 2025-03-10 | Vafseo | $858 |
| Akebia Therapeutics | Travel · 2025-03-09 | Vafseo | $63 |
| Akebia Therapeutics | Travel · 2025-03-09 | Vafseo | $167 |
| Akebia Therapeutics | Paid to speak or teach · 2025-03-07 | Vafseo | $1,716 |
| Akebia Therapeutics | Paid to speak or teach · 2025-03-07 | Vafseo | $1,430 |
| Akebia Therapeutics | Meals · 2025-03-06 | Vafseo | $122 |
| Akebia Therapeutics | Meals · 2025-03-06 | Vafseo | $37 |
| Akebia Therapeutics | Travel · 2025-03-06 | Vafseo | $57 |
| Akebia Therapeutics | Travel · 2025-03-06 | Vafseo | $61 |
| Akebia Therapeutics | Travel · 2025-03-06 | Vafseo | $29 |
| Calliditas Therapeutics US | Travel · 2025-03-05 | Tarpeyo | $100 |
| Calliditas Therapeutics US | Travel · 2025-03-05 | Tarpeyo | $411 |
| Akebia Therapeutics | Meals · 2025-03-05 | Vafseo | $97 |
| Akebia Therapeutics | Travel · 2025-03-05 | Vafseo | $92 |
| Akebia Therapeutics | Travel · 2025-03-05 | Vafseo | $665 |
| Akebia Therapeutics | Travel · 2025-03-05 | Vafseo | $67 |
| Amgen | Paid to speak or teach · 2025-03-04 | Tavneos | $2,800 |
| Travere Therapeutics | Meals · 2025-03-04 | None | $19 |
| Amgen | Travel · 2025-03-03 | Tavneos | $262 |
| Amgen | Paid to speak or teach · 2025-03-03 | Tavneos | $3,360 |
| Amgen | Paid to speak or teach · 2025-03-03 | Tavneos | $560 |
| Amgen | Travel · 2025-03-03 | Tavneos | $173 |
| Amgen | Meals · 2025-03-03 | Tavneos | $26 |
| Calliditas Therapeutics US | Meals · 2025-03-03 | Tarpeyo | $125 |
| Novartis Pharmaceuticals | Meals · 2025-02-27 | Fabhalta | $29 |
| Novartis Pharmaceuticals | Meals · 2025-02-27 | Fabhalta | $24 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-27 | Kerendia | $78 |
| Amgen | Travel · 2025-02-25 | Tavneos | $602 |
| Amgen | Meals · 2025-02-20 | Tavneos | $98 |
| Calliditas Therapeutics US | Honoraria · 2025-02-20 | Tarpeyo | $2,000 |
| Akebia Therapeutics | Paid to speak or teach · 2025-02-18 | Vafseo | $1,716 |
| Akebia Therapeutics | Paid to speak or teach · 2025-02-18 | Vafseo | $5,148 |
| Amgen | Paid to speak or teach · 2025-02-14 | Tavneos | $1,120 |
| Amgen | Travel · 2025-02-14 | Tavneos | $107 |
| Amgen | Paid to speak or teach · 2025-02-14 | Tavneos | $3,360 |
| Calliditas Therapeutics US | Honoraria · 2025-02-13 | Tarpeyo | $3,000 |
| Amgen | Paid to speak or teach · 2025-02-12 | Tavneos | $2,240 |
| Amgen | Paid to speak or teach · 2025-02-12 | Tavneos | $3,360 |
| Amgen | Travel · 2025-02-12 | Tavneos | $461 |
| Fresenius USA Marketing | Meals · 2025-02-12 | Velphoro | $18 |
| Amgen | Meals · 2025-02-11 | Tavneos | $125 |
| Amgen | Travel · 2025-02-10 | Tavneos | $162 |
| Amgen | Travel · 2025-02-10 | Tavneos | $8 |
| Amgen | Travel · 2025-02-10 | Tavneos | $363 |
| Amgen | Meals · 2025-02-10 | Tavneos | $10 |
| Calliditas Therapeutics US | Travel · 2025-02-09 | Tarpeyo | $209 |
| Calliditas Therapeutics US | Travel · 2025-02-09 | Tarpeyo | $773 |
| Calliditas Therapeutics US | Travel · 2025-02-09 | Tarpeyo | $533 |
| Calliditas Therapeutics US | Meals · 2025-02-09 | Tarpeyo | $124 |
| Calliditas Therapeutics US | Honoraria · 2025-02-05 | Tarpeyo | $3,000 |
| Travere Therapeutics | Meals · 2025-02-04 | None | $21 |
| Lilly USA | Meals · 2025-02-03 | Jardiance | $35 |
| Amgen | Paid to speak or teach · 2025-02-03 | Tavneos | $2,240 |
| Amgen | Travel · 2025-02-03 | Tavneos | $135 |
| Amgen | Paid to speak or teach · 2025-02-03 | Tavneos | $3,360 |
| Amgen | Meals · 2025-02-03 | Tavneos | $91 |
| Calliditas Therapeutics US | Travel · 2025-01-30 | Tarpeyo | $481 |
| Calliditas Therapeutics US | Travel · 2025-01-30 | Tarpeyo | $157 |
| Calliditas Therapeutics US | Meals · 2025-01-30 | Tarpeyo | $30 |
| Calliditas Therapeutics US | Honoraria · 2025-01-30 | Tarpeyo | $3,000 |
| Amgen | Travel · 2025-01-29 | Tavneos | $335 |
| Amgen | Travel · 2025-01-29 | Tavneos | $201 |
| Amgen | Travel · 2025-01-29 | Tavneos | $329 |
| Amgen | Travel · 2025-01-29 | Tavneos | $136 |
| Amgen | Travel · 2025-01-29 | Tavneos | $9 |
| Amgen | Travel · 2025-01-29 | Tavneos | $97 |
| Amgen | Meals · 2025-01-29 | Tavneos | $89 |
| Calliditas Therapeutics US | Meals · 2025-01-29 | Tarpeyo | $114 |
| Amgen | Paid to speak or teach · 2025-01-27 | Tavneos | $2,240 |
| Amgen | Paid to speak or teach · 2025-01-27 | Tavneos | $3,360 |
| Amgen | Paid to speak or teach · 2025-01-27 | Tavneos | $3,360 |
| Akebia Therapeutics | Paid to speak or teach · 2025-01-27 | Vafseo | $3,432 |
| Akebia Therapeutics | Paid to speak or teach · 2025-01-27 | Vafseo | $1,716 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-23 | Jardiance | $31 |
| Amgen | Paid to speak or teach · 2025-01-22 | Tavneos | $2,800 |
| Amgen | Meals · 2025-01-22 | Tavneos | $94 |
| Amgen | Travel · 2025-01-21 | Tavneos | $565 |
| Amgen | Travel · 2025-01-21 | Tavneos | $174 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-18 | Kerendia | $113 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-18 | Kerendia | $66 |
| Amgen | Meals · 2025-01-18 | Tavneos | $49 |
| Amgen | Meals · 2025-01-17 | Tavneos | $125 |
| Amgen | Travel · 2025-01-16 | Tavneos | $1,396 |
| Amgen | Travel · 2025-01-13 | Tavneos | $529 |
| Akebia Therapeutics | Travel · 2025-01-10 | Vafseo | $87 |
| Akebia Therapeutics | Travel · 2025-01-10 | Vafseo | $61 |
| Akebia Therapeutics | Travel · 2025-01-10 | Vafseo | $189 |
| Akebia Therapeutics | Meals · 2025-01-10 | Vafseo | $10 |
| Akebia Therapeutics | Travel · 2025-01-10 | Vafseo | $255 |
| Amgen | Travel · 2025-01-09 | Tavneos | $368 |
| Amgen | Consulting · 2025-01-09 | Tavneos | $1,585 |
| Ardelyx | Meals · 2025-01-08 | Ibsrela | $28 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $274,215
| Amgen | Tavneos | $118,697 | 145 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $47,569 | 47 payments
|
| Fresenius USA Marketing | Velphoro | $33,814 | 71 payments
|
| Calliditas Therapeutics US | Tarpeyo | $29,598 | 42 payments
|
| Travere Therapeutics | None | $19,004 | 38 payments
|
| Outset Medical | None | $11,892 | 2 payments
|
| Kyowa Kirin | Crysvita | $9,082 | 12 payments
|
| Novartis Pharmaceuticals | Fabhalta | $4,174 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $93 | 4 payments
|
| Ardelyx | Ibsrela | $85 | 4 payments
|
| Lilly USA | Jardiance | $69 | 3 payments
|
| Alexion Pharmaceuticals | Ultomiris | $48 | 2 payments
|
| GlaxoSmithKline | Jesduvroq | $27 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $25 | 1 payment
|
| Veloxis Pharmaceuticals | Envarsus | $20 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $19 | 1 payment
|
2023: $209,993
| Amgen | Tavneos | $99,821 | 134 payments
|
| Outset Medical | None | $60,643 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $35,068 | 37 payments
|
| Travere Therapeutics | None | $9,352 | 26 payments
|
| Fresenius USA Marketing | Velphoro | $4,431 | 9 payments
|
| Edwards Lifesciences | None | $202 | 1 payment
|
| GlaxoSmithKline | Benlysta | $131 | 5 payments
|
| Vifor Pharma | Veltassa | $93 | 4 payments
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $74 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $67 | 3 payments
|
| Aurinia Pharma U.S. | Lupkynis | $35 | 2 payments
|
| Novartis Pharmaceuticals | None | $29 | 1 payment
|
| Ardelyx | Ibsrela | $27 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $22 | 1 payment
|
2022: $240,358
| Outset Medical | None | $97,010 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $64,322 | 61 payments
|
| Amgen | Tavneos | $56,136 | 82 payments
|
| Fresenius USA Marketing | Velphoro | $15,835 | 31 payments
|
| Akebia Therapeutics | None | $6,630 | 2 payments
|
| Vifor Pharma | Veltassa | $213 | 12 payments
|
| Aurinia Pharma U.S. | Lupkynis | $122 | 1 payment
|
| GlaxoSmithKline | Benlysta | $59 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $18 | 1 payment
|
| Exeltis USA | Purified Cortrophin Gel | $13 | 1 payment
|
2021: $101,291
| Bayer HealthCare Pharmaceuticals | Kerendia | $28,771 | 23 payments
|
| Fresenius USA Marketing | Velphoro | $26,129 | 42 payments
|
| Outset Medical | None | $24,565 | 6 payments
|
| Vifor Pharma | Veltassa | $11,578 | 28 payments
|
| Akebia Therapeutics | Auryxia | $8,190 | 5 payments
|
| Otsuka America Pharmaceutical | Jynarque | $1,845 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $119 | 6 payments
|
| Amgen | Parsabiv | $79 | 4 payments
|
| GlaxoSmithKline | Benlysta | $16 | 1 payment
|
2020: $461,913
| Outset Medical | None | $437,570 | 17 payments
|
| Fresenius USA Marketing | Velphoro | $9,917 | 19 payments
|
| Relypsa | Veltassa | $5,839 | 8 payments
|
| Akebia Therapeutics | None | $3,900 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $1,890 | 9 payments
|
| Genzyme | None | $1,841 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | Jynarque | $858 | 1 payment
|
| Amgen | Parsabiv | $40 | 2 payments
|
| Otsuka America Pharmaceutical | Jynarque | $37 | 2 payments
|
| Alexion Pharmaceuticals | Ultomiris | $21 | 1 payment
|
2019: $156,923
| Outset Medical | None | $87,611 | 12 payments
|
| Relypsa | Veltassa | $41,596 | 113 payments
|
| Fresenius USA Marketing | Velphoro | $26,419 | 35 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $678 | 5 payments
|
| Bard Peripheral Vascular | None | $150 | 1 payment
|
| Abiomed | Impella | $131 | 2 payments
|
| Otsuka America Pharmaceutical | Jynarque | $131 | 10 payments
|
| Alexion Pharmaceuticals | None | $124 | 1 payment
|
| Amgen | Aranesp | $83 | 4 payments
|
Professional record
- NPI
- 1487685368
- Licence
- CA A69276California A69276: Current · expires 2026-11-30
- Trained
- University of California, Geffen School of Medicine, 1998
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA GR0002540
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-07-06
- NPI last updated
- 2020-05-27
- NPI record certified
- 2020-05-27
This is when the NPI record was last certified, not a medical board exam.